139 related articles for article (PubMed ID: 38546059)
1. Association of the CXCL12 rs1801157 Polymorphism with Breast Cancer Risk: A Meta-Analysis.
Alijanpour A; Golshan A; Vakili-Ojarood M; Shirinzadeh-Dastgiri A; Naseri A; Karimi-Zarchi M; Hajizadeh N; Barahman M; Azizi S; Aghasipour M; Khajehnoori S; Aghili K; Neamatzadeh H
Asian Pac J Cancer Prev; 2024 Mar; 25(3):767-776. PubMed ID: 38546059
[TBL] [Abstract][Full Text] [Related]
2. Lack of an Association between the SDF-1 rs1801157 Polymorphism and Coronary Heart Disease: A Meta-Analysis.
Wu N; Zhang X; Jia P; Jia D
Sci Rep; 2015 Jul; 5():11803. PubMed ID: 26133117
[TBL] [Abstract][Full Text] [Related]
3. The CXCL12 G801A polymorphism and cancer risk: evidence from 17 case-control studies.
Gong H; Tan M; Wang Y; Shen B; Liu Z; Zhang F; Liu Y; Qiu J; Bao E; Fan Y
Gene; 2012 Nov; 509(2):228-31. PubMed ID: 22939870
[TBL] [Abstract][Full Text] [Related]
4. CXCL12 G801A polymorphism and breast cancer risk: a meta-analysis.
Shen W; Cao X; Xi L; Deng L
Mol Biol Rep; 2012 Feb; 39(2):2039-44. PubMed ID: 21643956
[TBL] [Abstract][Full Text] [Related]
5. CXCL12 rs1801157 polymorphism in patients with breast cancer, Hodgkin's lymphoma, and non-Hodgkin's lymphoma.
de Oliveira KB; Oda JM; Voltarelli JC; Nasser TF; Ono MA; Fujita TC; Matsuo T; Watanabe MA
J Clin Lab Anal; 2009; 23(6):387-93. PubMed ID: 19927352
[TBL] [Abstract][Full Text] [Related]
6. The SDF-1 rs1801157 Polymorphism is Associated with Cancer Risk: An Update Pooled Analysis and FPRP Test of 17,876 Participants.
Tong X; Ma Y; Deng H; Wang X; Liu S; Yan Z; Peng S; Fan H
Sci Rep; 2016 Jun; 6():27466. PubMed ID: 27265091
[TBL] [Abstract][Full Text] [Related]
7. The CXCL12 G801A polymorphism is associated with cancer risk: a meta-analysis.
Zhu K; Jiang B; Hu R; Yang Y; Miao M; Li Y; Liu Z
PLoS One; 2014; 9(9):e108953. PubMed ID: 25268356
[TBL] [Abstract][Full Text] [Related]
8. The CXCL12 rs1801157 polymorphism and risk of colorectal cancer: a meta-analysis.
Xu K; Dai H; Wang S; Zhang J; Liu T
Onco Targets Ther; 2018; 11():2445-2452. PubMed ID: 29760554
[TBL] [Abstract][Full Text] [Related]
9. CXCL12 G801A polymorphism and cancer risk: An updated meta-analysis.
Meng D; Wu YX; Heerah V; Peng S; Chu MD; Xu YJ; Xiong WN; Xu SY
J Huazhong Univ Sci Technolog Med Sci; 2015 Jun; 35(3):319-326. PubMed ID: 26072067
[TBL] [Abstract][Full Text] [Related]
10. The G801A polymorphism in the CXCL12 gene and risk of breast carcinoma: evidence from a meta-analysis including 2,931 subjects.
Xia Y; Guo XG; Ji TX
Asian Pac J Cancer Prev; 2014; 15(6):2857-61. PubMed ID: 24761914
[TBL] [Abstract][Full Text] [Related]
11. CXCL12 rs1801157 polymorphism and expression in peripheral blood from breast cancer patients.
de Oliveira KB; Guembarovski RL; Oda JM; Mantovani MS; Carrera CM; Reiche EM; Voltarelli JC; da Silva do Amaral Herrera AC; Watanabe MA
Cytokine; 2011 Aug; 55(2):260-5. PubMed ID: 21592819
[TBL] [Abstract][Full Text] [Related]
12. Associations of CXCL12 polymorphisms with clinicopathological features in breast cancer: a case-control study.
Lin S; Zheng Y; Wang M; Zhou L; Zhu Y; Deng Y; Wu Y; Zhang D; Li N; Kang H; Dai Z
Mol Biol Rep; 2022 Mar; 49(3):2255-2263. PubMed ID: 35079936
[TBL] [Abstract][Full Text] [Related]
13. CXCL12-3' G801A polymorphism is not a risk factor for breast cancer.
Kruszyna Ł; Lianeri M; Rubis B; Knuła H; Rybczyńska M; Grodecka-Gazdecka S; Jagodziński PP
DNA Cell Biol; 2010 Aug; 29(8):423-7. PubMed ID: 20406099
[TBL] [Abstract][Full Text] [Related]
14. Association of a LSP1 gene rs3817198T>C polymorphism with breast cancer risk: evidence from 33,920 cases and 35,671 controls.
Chen MB; Li C; Shen WX; Guo YJ; Shen W; Lu PH
Mol Biol Rep; 2011 Oct; 38(7):4687-95. PubMed ID: 21127985
[TBL] [Abstract][Full Text] [Related]
15. Association of rs1801157 single nucleotide polymorphism of CXCL12 gene in breast cancer in Pakistan and
Khalid S; Hanif R
PeerJ; 2017; 5():e3822. PubMed ID: 28929029
[TBL] [Abstract][Full Text] [Related]
16. The association between two polymorphisms in the TYMS gene and breast cancer risk: a meta-analysis.
Wang J; Wang B; Bi J; Di J
Breast Cancer Res Treat; 2011 Jul; 128(1):203-9. PubMed ID: 21188629
[TBL] [Abstract][Full Text] [Related]
17. Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia.
Butrym A; Gebura K; Iwaszko M; Kuliczkowski K; Bogunia-Kubik K; Mazur G
HLA; 2016 Jun; 87(6):432-8. PubMed ID: 27173875
[TBL] [Abstract][Full Text] [Related]
18. Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in Taiwan.
Lin GT; Tseng HF; Yang CH; Hou MF; Chuang LY; Tai HT; Tai MH; Cheng YH; Wen CH; Liu CS; Huang CJ; Wang CL; Chang HW
OMICS; 2009 Apr; 13(2):165-72. PubMed ID: 19196101
[TBL] [Abstract][Full Text] [Related]
19. XPD Asp312Asn and Lys751Gln polymorphisms and breast cancer susceptibility: a meta-analysis.
Yan Y; Liang H; Light M; Li T; Deng Y; Li M; Li S; Qin X
Tumour Biol; 2014 Mar; 35(3):1907-15. PubMed ID: 24101192
[TBL] [Abstract][Full Text] [Related]
20. Association between tumor necrosis factor-α-308G/A gene polymorphism and susceptibility to pre-eclampsia: An updated meta-analysis.
Wang L; Qu G; Wu W; Tang X; Sun Y
Cytokine; 2018 Nov; 111():278-286. PubMed ID: 30245306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
